The company said, “The Company is not aware of any material developments or changes to its operating or financial condition that precipitated the volume and price movements that occurred on July 15, 2025. There have been no material adverse changes to the company’s operating results, its business, strategy, or prospects other than what has been disclosed publicly by the Company to date, including an amendment to the Exchange Agreement with FITTERS Diversified Berhad announced on July 7, 2025.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYCC:
- Cyclacel Pharmaceuticals Amends Exchange Agreement with FITTERS
- Cyclacel announces amendment to exchange agreement with Fitters
- Cyclacel announces publication of preclinical data on plogosertib
- Upcoming Stock Splits This Week (July 7 to July 11) – Stay Invested
- Cyclacel Pharmaceuticals trading halted, news pending